Embody vs Remedy Meds vs PlexusDx: GLP-1 provider comparison

Last reviewed: September 1, 2026 Last updated: September 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Embody and Remedy Meds target different medication tiers, which shapes their pricing and transparency models. Embody publishes standard-dose semaglutide and tirzepatide pricing upfront—$299/month and $349/month respectively, month-to-month—and includes unlimited provider visits, 24/7 clinical chat, and a 6-month money-back guarantee (full terms not captured). Remedy Meds shows only microdose pricing in the captured intake flow ($189/month for either semaglutide or tirzepatide microdose), published only after completing an intake quiz; standard-dose pricing was not available during July 2026 capture.

PlexusDx publishes pricing for both tiers: microdose GLP-1 at $129/month month-to-month, semaglutide injection (standard dose) at $189/month month-to-month, and tirzepatide injection at $289/month month-to-month, with lower committed-term rates available. For readers who know they want standard-dose injectable semaglutide or tirzepatide, Embody's published prices anchor expectations but run $110–$60/month higher than PlexusDx's month-to-month standard-dose rates. For readers exploring microdose protocols, Remedy Meds' $189/month matches PlexusDx's standard-dose semaglutide month-to-month rate, while PlexusDx's dedicated microdose protocol sits at $129/month.

The format constraint matters: as of July 2026, Embody offered injectable formats only, and Remedy Meds surfaced only microdose options in the captured flow. PlexusDx offers injectable and oral formulations across both standard and microdose tiers. Pricing transparency also diverges—Embody and PlexusDx publish month-to-month prices before signup; Remedy Meds reveals pricing only after intake completion.

At-a-glance comparison

Pricing verified July 20–21, 2026. Embody and PlexusDx pricing published on public sites; Remedy Meds pricing appeared only after intake quiz completion.

Like-for-like pricing and 12-month costs

Direct apples-to-apples comparison is limited because Embody publishes only standard-dose injectable pricing and Remedy Meds surfaced only microdose pricing in the captured intake flow. No standard-dose pricing was available from Remedy Meds during the July 2026 capture, and Embody did not publish microdose options.

Standard-dose injectable comparison (month-to-month)

Embody and PlexusDx both publish standard-dose injectable prices. Remedy Meds does not publish standard-dose pricing in the captured flow, so it is excluded from this tier comparison.

PlexusDx also offers 3-month and 6-month committed rates for standard-dose injectables. The 6-month semaglutide injection rate is $149/month (prepaid per-month equivalent), which yields a 12-month cost of $1,788 (our calculation), $1,800 below Embody's month-to-month annual cost. The 6-month tirzepatide injection rate is $249/month (prepaid per-month equivalent), yielding a 12-month cost of $2,988 (our calculation), $1,200 below Embody's month-to-month annual cost.

Microdose comparison (month-to-month)

Remedy Meds and PlexusDx both offer microdose protocols. Embody did not publish microdose options as of July 2026.

PlexusDx microdose GLP-1 protocol is offered month-to-month only; no committed-term rates are published for the microdose tier. Over 12 months, PlexusDx microdose totals $1,548 (our calculation), $720 below Remedy Meds' microdose annual cost.

Decision factors beyond price

Guarantees and results pledges

Embody offers a 6-month money-back guarantee; the headline was captured but full conditions were not documented. Remedy Meds advertises a Remedy Weight Loss Warranty described as "guaranteed or it's free" with terms that apply; conditions were not captured. Both guarantees may provide downside protection for first-time users, but because the specific eligibility criteria, refund mechanics, and exclusions are not published in the captured evidence, readers should verify terms at checkout before relying on these pledges as decision inputs.

PlexusDx does not offer a money-back guarantee or results warranty. All three providers operate month-to-month cancellation models, which limits ongoing financial risk independent of guarantee structures.

Provider access and support

Embody includes unlimited provider visits and 24/7 clinical chat support in the monthly price. Remedy Meds includes unlimited video visits with clinicians, always-on phone support, and advertises a 100% U.S.-based care team. PlexusDx includes the initial provider visit and follow-up care in the monthly price; support is asynchronous and does not include 24/7 phone or chat access.

For readers who anticipate frequent clinical questions or prefer synchronous communication (phone or live chat), Embody's 24/7 chat or Remedy's phone support may justify higher monthly fees. For readers comfortable with asynchronous check-ins and standard follow-up cadences, PlexusDx's included provider access covers the care pathway at a lower monthly cost.

Pricing transparency and intake friction

Embody and PlexusDx publish month-to-month prices on public pages before signup. Remedy Meds shows pricing only after completing an intake quiz. This difference affects early-stage decision-making: transparent pricing allows budget filtering before time investment, while intake-gated pricing can surface personalized offers but adds friction for comparison shoppers.

Readers who value upfront cost certainty will find Embody and PlexusDx easier to evaluate. Readers open to intake-driven pricing may discover tailored options through Remedy Meds' quiz flow, but should confirm that the post-intake price matches the $189/month microdose rate documented here (captured July 20, 2026) and clarify whether standard-dose options are available.

Medication format and tier availability

Embody offers injectable semaglutide and tirzepatide in standard doses only (as of July 2026 capture). Remedy Meds surfaced microdose options only in the captured intake flow; injectable format was documented, and standard-dose availability was not confirmed. PlexusDx offers both injectable and oral capsule formulations across standard and microdose tiers.

For readers who prefer or require oral administration—whether for injection aversion, travel convenience, or lifestyle fit—PlexusDx provides that option at published prices (semaglutide oral capsules $289/month month-to-month, tirzepatide oral capsules $349/month month-to-month, with lower committed-term rates). Neither Embody nor Remedy Meds advertised oral formats in the captured evidence.

For readers exploring microdose protocols for maintenance or minimal effective dose strategies, Remedy Meds and PlexusDx both offer documented microdose options; Embody does not publish a microdose tier.

Choose Embody if…

• You want standard-dose semaglutide or tirzepatide injectable treatment with published upfront pricing and are willing to pay $299–$349/month month-to-month.
• 24/7 clinical chat access and unlimited provider visits are high-priority features for you, and the $110–$60/month premium over PlexusDx's standard-dose month-to-month rates is justified by that support model.
• A 6-month money-back guarantee (terms to be confirmed at signup) provides meaningful downside protection in your decision calculus.
• You prefer a month-to-month model without needing to evaluate committed-term pricing options.

Choose Remedy Meds if…

• You are exploring microdose GLP-1 protocols specifically and are comfortable with pricing revealed after intake completion.
• Unlimited video visits with clinicians and always-on phone support are worth $60/month more than PlexusDx's microdose month-to-month rate.
• A U.S.-based care team is a stated priority, and the Remedy Weight Loss Warranty (terms to be confirmed at signup) aligns with your risk tolerance.
• You do not require oral formulations or standard-dose options (not surfaced in the captured flow as of July 2026).

Choose PlexusDx if…

• You want transparent, published pricing across both standard and microdose tiers before starting an intake, with the flexibility to choose injectable or oral formats.
• Minimizing monthly cost is a priority: PlexusDx's semaglutide injection month-to-month rate ($189) sits $110/month below Embody's standard-dose rate, and the microdose protocol ($129) runs $60/month below Remedy Meds' microdose rate.
• You are open to committed-term pricing to reduce per-month costs further—PlexusDx's 6-month semaglutide injection rate ($149/month prepaid equivalent) yields 12-month savings of $1,800 vs Embody's month-to-month cost (our calculation).
• You do not require 24/7 live chat or phone support and are comfortable with asynchronous provider communication and standard follow-up cadences.

Methodology and freshness

All pricing and feature data were captured from public pages or post-intake flows between July 20 and July 21, 2026. Embody pricing was published on the public site; Remedy Meds pricing appeared only after completing the intake quiz. PlexusDx pricing is published on product pages. Standard ongoing rates and prepaid totals only, verified at the dates shown.

The 12-month cost calculations are our calculations, derived by multiplying monthly rates by 12. Prepaid per-month equivalents for PlexusDx's 3-month and 6-month rates are labeled as such. Readers should confirm current pricing, guarantee terms, and product availability at checkout, as telehealth offerings can change.

Compounded GLP-1 medications discussed in this comparison are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Frequently Asked Questions

Does Remedy Meds offer standard-dose semaglutide or tirzepatide?

Standard-dose pricing was not published or surfaced in the July 2026 intake flow capture. Only microdose options at $189/month (either compound) appeared. Readers interested in standard-dose treatment through Remedy Meds should complete the intake to confirm current availability and pricing.

Can I get oral semaglutide or tirzepatide from Embody or Remedy Meds?

Neither provider advertised oral formulations in the captured evidence. Embody offered injectable semaglutide and tirzepatide only. Remedy Meds surfaced injectable microdose only in the captured flow. PlexusDx offers both injectable and oral capsule formats across standard and microdose tiers.

What are the conditions of Embody's 6-month money-back guarantee?

The guarantee headline was captured, but full eligibility criteria, refund mechanics, and exclusions were not documented in the July 2026 capture. Readers should verify terms directly with Embody at signup before relying on the guarantee as a decision factor.

Why is PlexusDx's microdose GLP-1 protocol $60/month cheaper than Remedy Meds' microdose option?

PlexusDx publishes a dedicated microdose protocol at $129/month with included provider visit and follow-up care. Remedy Meds bundles unlimited video visits, always-on phone support, and a U.S.-based care team at $189/month. The $60 difference reflects support model and care-team positioning rather than medication formulation differences.

Does PlexusDx offer 24/7 phone or chat support like Embody and Remedy Meds?

No. PlexusDx includes the initial provider visit and follow-up care in the monthly price, with asynchronous communication. Embody offers 24/7 clinical chat; Remedy Meds offers always-on phone support. Readers who prioritize synchronous, real-time support should weigh that feature against the $60–$110/month price differences documented here.

Sources

• Embody public pricing page, accessed July 21, 2026
• Remedy Meds intake flow and pricing disclosure, accessed July 20, 2026
• PlexusDx product pages (semaglutide injection, tirzepatide injection, microdose GLP-1 protocol), accessed September 1, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.